Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

ADIR describes new PDE IV-inhibitory flavones

June 17, 1998

Biogen seeks partners to continue development of gelsolin

June 16, 1998

New antiallergic and antiinflammatory compounds developed by Astra researchers

June 11, 1998

tgAAV-CFTR research results published in The Lancet

June 11, 1998

Pfizer discloses indazole inhibitors of PDE and TNF production

June 11, 1998

Byk Gulden patents another series of thiazole PDE IV inhibitors

June 9, 1998

Genome Therapeutics reaches milestone in Schering-Plough alliance

June 9, 1998

Bronchotherapeutic agents in development at Byk Gulden

June 8, 1998

Clinical protocol for phase I/II testing of tgAAV-CFTR

June 5, 1998

Zyrtec approved for use in children as young as two years

June 5, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...